Summary of bound residue chemistry session

N E Weber¹

Affiliations

N E Weber. Drug Metab Rev. 1990.

. 1990;22(6-8):677-80.

doi: 10.3109/03602539008991461.

N E Weber¹

¹ Food and Drug Administration, Center for Veterinary Medicine, Rockville, Maryland 20857.

No abstract available

Similar articles

Development of a unified approach to evaluate the toxicological potential of bound residues.
Lu AY, Chiu SH, Wislocki PG. Lu AY, et al. Drug Metab Rev. 1990;22(6-8):891-904. doi: 10.3109/03602539008991477. Drug Metab Rev. 1990. PMID: 2102465 Review. No abstract available.
Formation and biological evaluation of ronidazole bound residues.
Wislocki PG, Lu AY. Wislocki PG, et al. Drug Metab Rev. 1990;22(6-8):649-61. doi: 10.3109/03602539008991459. Drug Metab Rev. 1990. PMID: 2102447 Review. No abstract available.
Overview of bound residue chemistry.
Weber NE. Weber NE. Drug Metab Rev. 1990;22(6-8):611-5. doi: 10.3109/03602539008991456. Drug Metab Rev. 1990. PMID: 2102444 Review. No abstract available.
Is the toxicity of cysteine conjugates formed during mercapturic acid biosynthesis relevant to the toxicity of covalently bound drug residues?
Stevens JL, Wallin A. Stevens JL, et al. Drug Metab Rev. 1990;22(6-8):617-35. doi: 10.3109/03602539008991457. Drug Metab Rev. 1990. PMID: 2102445 Review.
A contribution to safety assessment of veterinary drug residues: in vitro/ex vivo studies on the intestinal toxicity and transport of covalently bound residues.
Klee S, Baumung I, Kluge K, Ungemach FR, Horne E, O'Keeffe M, De Angelis I, Vignoli AL, Zucco F, Stammati A. Klee S, et al. Xenobiotica. 1999 Jun;29(6):641-54. doi: 10.1080/004982599238452. Xenobiotica. 1999. PMID: 10426562